Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19 #virology #DrugDiscovery https://t.co/e3aIjgmuP3 https://t.co/yjSXMx4UEJ
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – Sep 2023Where it's discussed
-
X / Twitter26 posts
-
YouTube1 videos
AI synopsis
What people are saying
The overall tone reflects high enthusiasm about the breakthrough, with posts highlighting the peptide's effectiveness against SARS-CoV-2 and its potential as a new antiviral approach. Words like 'potent' and mentions of organizations such as @NatureComms and #WellcomeTrust underscore both the scientific promise and broad interest in this development.
Most discussions praise the findings, emphasizing the effectiveness and potential of multivalent bicyclic peptides against COVID-19, using words like 'effective' and 'potently inhibit'.
Posts show high interest, with numerous hashtags, mentions of related fields like virology and drug discovery, and references to prominent organizations, indicating curiosity and relevance.
Users engage by sharing enthusiasm, retweeting from reputable sources, and emphasizing the significance of this research, although some posts are more promotional than analytical.
Discussion suggests the research could significantly influence antiviral strategies, with phrases like 'new antiviral modality' and references to potential therapeutic applications enhancing its perceived importance.
Abstract in brief
- COVID-19 has led to the swift creation of new antiviral treatments, including a novel approach using "Bicycles," which are specially structured peptides that target SARS-CoV-2.
- By screening bacteriophage libraries, researchers identified specific Bicycle binders that were enhanced from micromolar to nanomolar efficacy through a process called multimerization.
- Testing in mouse models showed that these multimerized and biparatopic Bicycles effectively reduce viral load and inflammation, highlighting their potential as a new antiviral strategy against evolving viruses like SARS-CoV-2.
Top posts
Most liked on X and BlueskyMultivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19 #virology #DrugDiscovery https://t.co/e3aIjgn2EB https://t.co/8OdXXzoa7F
1️⃣ Published: 16 June 2023 Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 https://t.co/ubkQV0HnPO
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
All mentions
Multivalent Bicyclic Peptides as Potent SARS-CoV-2 Inhibitors
This video discusses the development of multivalent bicyclic peptides as a new antiviral approach against SARS-CoV-2, demonstrating their enhanced efficacy through multimerization and promising results in mouse models.
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19 #virology #DrugDiscovery https://t.co/e3aIjgmuP3 https://t.co/yjSXMx4UEJ
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
RT @NatureComms: Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19…
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 @JamesLab9 #COVID19 #virology #DrugDiscovery https://t.co/e3aIjgn2EB https://t.co/8OdXXzoa7F
New Paper from I04 in @NatureComms https://t.co/eD2vcmTAXe (https://t.co/ds8vKMDBmf)
New from #The_MRC https://t.co/35sfokJgMC Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2.
New from #wellcometrust https://t.co/35sfokJgMC Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2.
1️⃣ Published: 16 June 2023 Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit #SARSCoV2 https://t.co/ubkQV0HnPO
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2 https://t.co/EOs4cSPgad